Titan Biotech Launches Second 'Saksham Niveshak' Campaign to Address Unclaimed Dividends
Titan Biotech Limited has announced its participation in the IEPFA's second 100 Days Campaign — 'Saksham Niveshak' — running from April 01, 2026 to July 09, 2026, aimed at helping shareholders claim unpaid or unclaimed dividends. The campaign follows an IEPFA circular dated March 27, 2026, and requires shareholders to update KYC details including PAN, bank account, nomination, and contact information. Shareholders must submit the relevant forms (ISR-1, ISR-2, SH-13, ISR-3) to the company's RTA, Beetal Financial & Computer Services Private Limited, before the July 9, 2026 deadline.
*this image is generated using AI for illustrative purposes only.
Titan Biotech Limited has formally notified its shareholders of its participation in the second 100 Days Campaign — "Saksham Niveshak" — launched by the Investor's Education and Protection Fund Authority (IEPFA), Ministry of Corporate Affairs. The intimation, filed on May 06, 2026, follows an IEPFA circular dated March 27, 2026, requesting companies to roll out the campaign to help shareholders claim unpaid or unclaimed dividends.
About the Saksham Niveshak Campaign
The second phase of the "Saksham Niveshak – 100 Days Campaign" is scheduled to run from April 01, 2026 to July 09, 2026. The campaign's primary objective is to create awareness among shareholders and enable them to update their personal and financial details so that unclaimed dividends can be credited to their bank accounts before being transferred to the Investor Education and Protection Fund (IEPF).
| Parameter: | Details |
|---|---|
| Campaign Name: | Saksham Niveshak – 100 Days Campaign (Second Phase) |
| Campaign Period: | April 01, 2026 to July 09, 2026 |
| Initiated By: | IEPFA, Ministry of Corporate Affairs |
| IEPFA Circular Date: | March 27, 2026 |
| Company Intimation Date: | May 06, 2026 |
| RTA: | Beetal Financial & Computer Services Private Limited |
Why Shareholders Need to Act
Since dividend on shares is payable only in electronic mode, dividends will be credited to a shareholder's bank account only after the relevant information and documents are updated. Shareholders are advised to update the following details with the company or its Registrar & Transfer Agent (RTA):
- PAN details
- Nomination details
- Contact information (postal address, mobile number)
- Bank account details
- Specimen signature
Shareholders holding shares in electronic form who have not claimed their dividend can do so by updating or modifying their details with their respective depository participants.
Required Forms and Submission Process
Shareholders are required to submit the following forms, available for download on the company's website at www.titanbiotechltd.com :
| Form: | Purpose |
|---|---|
| Form ISR-1: | Duly filled and signed, with self-attested KYC documents |
| Form ISR-2: | Duly filled and signed, with banker's attestation of signature + original cancelled cheque (name printed) or self-attested bank passbook/statement |
| Form SH-13: | For adding a nominee |
| Form ISR-3: | For opting out of nomination |
Physical copies of the completed forms are to be submitted to the company's RTA — M/s. Beetal Financial & Computer Services Private Limited ("Beetal") — at Beetal House, 3rd Floor, 99, Madangir, Behind Local Shopping Centre, Near Dada Harsukhdas Mandir, New Delhi – 110062.
Contact Information for Queries
Shareholders with queries regarding unpaid or unclaimed dividends or KYC updates may reach out through the following channels:
| Contact: | Details |
|---|---|
| Company Email: | cs@titanbiotechltd.com |
| Company Phone: | 011-49096502 / 011-27355742 |
| RTA Email: | beetalrta@gmail.com |
| RTA Phone: | 011-29961281-283 |
Shareholders are urged to submit all required documents before the campaign deadline of July 9, 2026 to ensure their unclaimed dividends are processed and credited accordingly.
Historical Stock Returns for Titan Biotech
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.08% | -6.05% | -7.41% | +139.60% | +420.09% | +635.71% |
What is the total value of unclaimed dividends held by Titan Biotech that could potentially be transferred to IEPF if shareholders miss the July 9, 2026 deadline?
How might IEPFA expand or enforce compliance mechanisms in future campaign phases if shareholder participation rates remain low across listed companies?
Could the mandatory shift to electronic-only dividend payments drive broader financial inclusion initiatives, and how might companies like Titan Biotech support shareholders in remote areas with limited digital access?
18
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
